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etter to the editorntimicrobial resistance proﬁle of pathogens isolated from
lood cultures in public and private hospitals in Brazilear Editor,
loodstream infections (BSI) are severe diseases associated
ith high mortality rates, longer length of hospital stay, and
levated costs. The spread of resistant microorganisms has
ecome a public health problem. For this reason, surveil-
ance measures have become a recognized need, since they
an help healthcare teams to monitor the occurrence of
osocomial infections and to identify the common causative
icroorganisms.1 The purpose of this study was to assess
he frequency and the antimicrobial resistance proﬁles of
athogens recovered from blood cultures in one public and
ne private hospital from Niterói city, Rio de Janeiro, Brazil.
Patients with bloodstream infection from one 227-bed pub-
ic general hospital and one 123-bed private general hospital
rom August 2009 to August 2010 were identiﬁed. In both hos-
itals, blood samples were cultured by automated methods
BacT/ALERT, bioMérieux Clinical Diagnostics – Marcy l’Etoile,
rance). Microbiological identiﬁcation and antimicrobial sus-
eptibility testing were performed in the public institution
sing the Vitek 2 automated system (bioMérieux). In the pri-
ate hospital, the organisms were identiﬁed using Enterokit
and Enterokit C (PROBAC do Brasil Produtos Bacteriológicos
tda. – São Paulo, Brazil). Antimicrobial susceptibility testing
as performed by disk diffusion method.2 Enterobacteriaceae
ere tested for carbapenemase production using the modiﬁed
odge test. E. coli, K. pneumoniae, K. oxytoca and P. mirabilis iso-
ateswere tested for extended spectrumbeta lactamase (ESBL)
roduction. Staphylococcus aureus isolates were submitted to
efoxitin disk diffusion test to conﬁrm oxacillin resistance.2
ifferences between intensive care unit (ICU) and wards of
ach hospital were assessed for statistical signiﬁcance using
he chi-squared test or Fisher’s exact test. The signiﬁcance
evel was set at p ≤ 0.05.
A total of 234 BSI episodes (one episode per patient) were
etected, yielding 254 isolates. There were 22 (7.5%) polymi-
robial episodes, the majority (n = 14, 63.6%) found in the
ublic hospital.Most of theBSI episodeswere causedby Entero-
acteriaceae (n = 113, 46.5%), followed by non-fermentative
ram-negative bacilli (n = 84, 34.6%). Enterobacteriaceae wereprevalent among isolates recovered from patients of wards
in both hospitals (n=31, 40.8%; n=51, 54.3%). The production
of ESBL was investigated; despite the Latin America SEN-
TRY program having shown that the rates of ESBL-producing
Enterobacteriaceae, especially K. pneumoniae and E. coli, are
among the highest in the world,3 only one strain of E. coli
was identiﬁed to be ESBL-producer in the wards of the pub-
lic hospital, and only one strain of K. pneumoniae in the ICU
of the same hospital. Carbapenems are used to treat severe
infections caused by multidrug-resistant organisms, espe-
cially by ESBL-producing pathogens. During the last decade,
carbapenem resistance has emerged among clinical isolates
of Enterobacteriaceae, and this has been increasingly attributed
to the production of -lactamases able to hydrolyze these
agents.4 We investigated carbapenemase production among
Enterobacteriaceae isolates and found, in the private hospital,
ten strains of K. pneumoniae and one strain of Klebsiella sp.
positive (Table 1).
The non-fermentative bacilli were the major cause of bac-
teremia in the ICU of the public hospital. In the private
hospital, non-fermentative bacilli were mostly recovered from
wards, Pseudomonas aeruginosa being the principal agent of
infection. Data collected by the Latin American SENTRY Pro-
gram showed that the prevalence of isolates resistant to all
antimicrobial agents, except polymyxins, has been contin-
uously increasing, and P. aeruginosa resistance rates were
slightly higher among isolates recovered in Brazil, compared
to other areas.3 All non-fermentative bacilli were suscepti-
ble to colistin in both hospitals. In our study, 23.1% of the
strains recovered from the public hospital ICU were resis-
tant to meropenem. In the private hospital, 87.5% and 60.9%
of strains recovered from ICU and wards, respectively, were
resistant to this antibiotic (Table 1).
Other studies have reported S. aureus as the major cause
of bloodstream infection in Brazil, South America, and
North America.3 The pattern of resistance observed in our
research was similar to other Brazilian hospitals where MRSA
accounted for 31.0% to 66.7% of the isolates (Table 1).5
Etiology and antimicrobial susceptibility patterns of
microorganisms recovered from blood culture varied between
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Table 1 – Characteristics of bacterial isolates recovered from blood cultures in participating public and private hospitals.
Characteristics, n (%) Public hospital Private hospital
ICU (n=57) Wards (n=76) ICU (n=27) Wards (n=94)
Polymicrobial infection 12 (21.1)a 2 (2.6) 0 (0.0) 8 (8.5)
Enterobacteriaceae 16 (28.1) 31 (40.8) 15 (55.6) 51 (54.3)
Escherichia coli 3 (5.3) 12 (15.8) 0 (0.0) 10 (10.6)
Klebsiella pneumoniae 4 (7.0) 11 (14.5) 5 (18.5) 14 (14.9)
Proteus mirabilis 5 (8.8) 2 (2.6) 7 (25.9) 21 (22.3)
Cephalosporins resistanceb 5 (31.3) 7 (22.6) 6 (40.0) 16 (31.4)
ESBL conﬁrmed positiveb 1 (33.3) 1 (20.0) 0 (0.0) 0 (0.0)
Modiﬁed Hodge test positiveb 0 (0.0) 0 (0.0) 3 (20.0) 8 (15.7)
Carbapenems resistanceb 1 (6.3) 0 (0.0) 4 (26.7) 9 (17.6)
Non-fermentative bacilli 29 (50.9)a 9 (11.8) 12 (44.4) 34 (36.2)
Acinetobacter calcoaceticus baumannii 15 (26.3) 3 (3.9) 3 (11.1) 9 (9.6)
Pseudomonas aeruginosa 13 (22.8) 5 (6.6) 8 (29.6) 24 (25.5)
Cephalosporins resistanceb 18 (62.1)a 1 (11.1) 9 (75.0) 22 (64.7)
Carbapenems resistanceb 16 (55.2) 1 (11.1) 10 (83.3) 21 (61.8)
Colistin resistanceb 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Amikacin resistanceb 3 (10.3) 0 (0.0) 8 (66.7) 15 (44.1)
Ciproﬂoxacin resistanceb 18 (62.1)a 1 (11.1) 12 (100.0) 26 (76.5)
Gram-positives 6 (10.5) 31 (40.8)a 0 (0.0) 9 (9.6)
Staphylococcus aureus 4 (7.0) 23 (30.3) 0 (0.0) 7 (7.4)
Oxacillin-resistance S. aureusb 3 (75.0) 11 (47.8) 0 (0.0) 5 (71.4)
a p≤ 0.05: statistically signiﬁcant.
b Prevalence: number of resistant isolates divided by the number of isolates tested. ICU, intensive care unit. Resistance to third- and/or fourth-
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5generation cephalosporins. Screening and conﬁrmatory tests for ex
was performed for Enterobacteriaceae (CLSI, 2010). Carbapenems res
inpatient units, pointing out the need for continuous surveil-
lance, since local data is essential to improve therapeutic
options, as well to prevent and control infections.
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